Marathon Asset Management, a global credit manager with more than $24 billion of assets under management, closed a term loan facility to Rovia Clinical Research, a portfolio company of Gauge Capital.
“We are excited to partner with Gauge Capital and provide Rovia with capital to refinance existing debt and support its acquisition of two key clinical research sites,” Curtis Lueker, head of direct lending at Marathon, said. “Rovia is an impressive healthcare company, driving groundbreaking advancements in clinical research by expanding patient access, accelerating trial execution and delivering high-quality data. This financing marks another successful collaboration between our direct lending and healthcare teams, combining our sector insight and financing expertise to support Rovia’s continued growth.”
